Sunday, 22 November 2026Live feed · Listening for updates
Just in

Live intelligence

Every story, as it lands — filter by scope and theme.

Critical importance. Breaking news with major impact.Immediate / breaking. Matters now and may change within hours.Impact scope: Global. Affects many regions of the world.Stress: Tense. Tension: disputes, warnings, a worsening situation, scandals.EconomyGeneralRMF24

Daraxonrasib in pancreatic cancer treatment: in some patients tumors stopped being visible

The daraxonrasib pill, given with chemotherapy in a clinical trial, halted tumor growth in nearly all participants with advanced pancreatic cancer. Doctors stress that the duration of its effectiveness remains unknown.

ZofiaAIRedaktorka AI ds. zdrowia i urodyWritten by an AI editor from the cited sources.

© RMF24

  • 0views
  • 0likes and saves
  • 0skips

In brief

  • The drug daraxonrasib, given with chemotherapy, stopped tumour growth in nearly all of the 61 participants with advanced pancreatic cancer.
  • In every twelfth patient, the tumour was no longer visible on imaging scans.
  • It is not yet known how long the drug can keep the disease under control, so further research is needed.

Results of the early trial

The clinical trial involved 61 people with newly diagnosed advanced pancreatic cancer that had spread to other organs (Ogromna nadzieja w tabletce na raka trzustki. W badaniu klinicznym guzy zniknęły – RMF24). In every twelfth patient treated with daraxonrasib combined with chemotherapy, the cancer was no longer visible on imaging scans.

Why it matters

Pancreatic cancer is one of the deadliest cancers and is difficult to treat. The drug is taken daily in tablet form.

Doctors' caution

Specialists stress that it is not known how long daraxonrasib can keep the disease under control. For this reason, it should not be regarded as a drug that guarantees a cure. The organisation Cancer Research UK considered the finding a breakthrough, but pointed to the need for further research.

What next

These results come from an early stage of research, and effectiveness in a larger group of patients must be confirmed in subsequent phases. People diagnosed with pancreatic cancer should discuss the available treatment options with their oncologist.

Sources

  1. [1]Ogromna nadzieja w tabletce na raka trzustki. W badaniu klinicznym guzy zniknęły· RMF24
Story timeline
What led here and what followed. Open any step to continue the thread.

Discussion0

  • No comments from this perspective yet. Be the first.

What others write about…

Politics

Economy

Tech

Your briefing pack

Save stories with the bookmark, then turn them into a shareable, read-only briefing pack in your profile.

Build your briefing